Related Experiment Video
Updated: Jul 31, 2026
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
Effectiveness of adenoidectomy and laser tympanic membrane fenestration
S P Cook1, L Brodsky, J S Reilly
1Division of Otolaryngology, Alfred I DuPont Hospital for Children, Wilmington, Delaware 19899, USA. scook@nemours.org
Insights
Laser tympanic membrane fenestration (LTMF) combined with adenoidectomy effectively treated middle ear disease in over 80% of children within 90 days. This approach offers an alternative to pressure equalization tubes, improving hearing and middle ear function.
Area of Science:
- Pediatric Otolaryngology
- Middle Ear Disease Management
- Minimally Invasive Surgical Techniques
Background:
- Adenoidectomy with or without tonsillectomy (A+/-T) is a common treatment for pediatric otitis media, often combined with pressure equalization tubes (PETs).
- Otorrhea and persistent tympanic membrane perforations are known complications associated with PET insertion.
- There is a need for alternative middle ear ventilation methods that minimize complications.
Purpose of the Study:
- To evaluate the efficacy of laser tympanic membrane fenestration (LTMF) as an adjunct to adenoidectomy for treating middle ear disease in children.
- To assess LTMF as an alternative to PET insertion for intermediate-duration middle ear ventilation.
- To determine the resolution rate of middle ear disease and restoration of middle ear function within 90 days post-procedure.
Main Methods:
- A multicenter, prospective pilot clinical cohort trial involving 50 children (96 ears) across four pediatric otolaryngology departments.
- Children undergoing A+/-T who would typically receive PETs were treated with LTMF using the Oto-LAM device.
- Clinical resolution was assessed at 30, 60, and 90 days postoperatively via clinical examination, pneumatic otoscopy, audiometry, and tympanometry.
Main Results:
- Clinical resolution of middle ear disease was observed in 88%, 86%, and 83% of treated ears at 30, 60, and 90 days, respectively.
- Normal hearing improved significantly, with 92% of ears achieving normal hearing at 90 days compared to 45% preoperatively.
- Preoperative tympanometry indicated significant middle ear dysfunction (Type C2 or B in 89% of ears), which improved to 12% by 90 days.
Conclusions:
- Laser tympanic membrane fenestration, when combined with adenoidectomy, demonstrates effectiveness in resolving middle ear disease in children.
- The procedure successfully restored normal middle ear function in over 80% of cases within 90 days.
- LTMF serves as a viable alternative to PET insertion, offering improved outcomes and potentially fewer complications.
Objective:
Adenoidectomy alone or with tonsillectomy (A+/-T) is an effective surgical intervention in the management of otitis media in children, especially when it is performed in conjunction with insertion of pressure equalization tubes (PETs). Otorrhea and persistent tympanic membrane (TM) perforation are frequent complications. This study evaluates the effectiveness of intermediate duration middle ear ventilation using laser tympanic membrane fenestration (LTMF) without tube insertion and as an adjunct to adenoidectomy in resolving middle ear disease within the first 90 days after surgery.
Study Design:
This pilot study was a multicenter, prospective clinical cohort trial. Institutional review board approval and informed consent were obtained. The study involved four tertiary care pediatric otolaryngology departments. Fifty children (96 ears) were treated with LTMF in conjunction with A+/-T from June 1, 1998, through March 30, 1999. Ages ranged from 9 months to 12 years. Patients undergoing A+/-T who would have been recommended for PET insertion instead underwent middle ear ventilation with LTMF using the Oto-LAM device (ESC/Sharplan, Yokneam, Israel). Patients were seen at 30, 60, and 90 days postoperatively. Resolution of otitis media with effusion was determined by clinical examination, which included pneumatic otoscopy, audiometry, and tympanometry.
Results:
Of the treated ears, 88%, 86%, and 83% had clinical resolution of middle ear disease at 30, 60, and 90 days, respectively. Preoperatively, 45% (n = 85) of ears had normal hearing; 92% (n = 49) had normal hearing at 90 days. Eighty-nine percent (n = 92) had type C2 or B tympanograms preoperatively, and 12% (n = 60) had type C2 or B at 90 days.
Conclusion:
Laser tympanic membrane fenestration in conjunction with adenoidectomy was effective in restoring normal middle ear function at 90 days post-treatment in greater than 80% of children who otherwise may have had placement of PETs.
